Phase I Units

Bulgaria I
MHAT Hospital Evropa OOD, Sofia Private Hospital
Section for clinical trials for bioavailability and bioequivalence of medicinal products

Intensive care and anaesthesiology monitoring

Continuous cardiovascular and vital signs monitoring

First in Men studies feasible

Investigators team GCP-inspected by Spanish, French, Austrian, Bulgarian, South African Authorities

Hospital certified by Ministry of Health, Bulgaria

Stability data not required

30–60 days approval time

24 beds

Bulgaria II
Queen Giovanna, Sofia, University Hospital

GCP-inspected by French and Bulgarian Authorities

Stability data not required

30–60 days approval time

18 beds

Bulgaria III
Ascendent Center for Clinical Trials, Sofia, Private Hospital

Gynecological examinations including histology at site

GCP-inspected by Bulgarian Authorities

Stability data not required

30–60 days approval time

12 beds

Turkey
Hakan Cetinsaya GCP and Research Center, Kayseri, Erciyes University Hospital

GCP-inspected by German, Spanish, Austrian, South African, Turkish Authorities

IMPD not required

Stability data not required

30–60 days approval time

56 beds

Jordan
Amman, Jordan Center of Pharmaceutical Research

GCP-inspected by French and Jordanian Authorities

Accredited by Gulf Cooperation Council (GCC) countries

IMPD not required

Stability data not required

14–21 days approval time

64 beds